Focusing on delivering innovative solutions and platforms for the life sciences industry, Honeywell today announced its collaboration with Bigfinite. The collaboration will concentrate on delivering new technology using artificial intelligence and machine learning to ease facilitate more active delivery of medical therapies to the biotech and pharma industries.
The two companies will combine Honeywell’s deep expertise in process automation and manages technology with Bigfinite’s data analytics, artificial intelligence, and machine learning platform, designed specifically for the biotechnology and pharmaceutical industries. In November 2019, Bigfinite announced that Honeywell Ventures had invested in its Series-B Financing.
To Inspire Digital Transformation to help enable faster delivery of medical therapies with Next-Generation Platform for Biotech and Pharma Industries to the biotech and pharma industries. The company aims a fast-track transformation through the adoption of new technologies on industry-leading platforms such as SAP and Oracle to help create next-generation, techno-savvy, smart enterprises that utilize out-of-box business models to deliver excellence.
Honeywell And Bigfinite will collaborate to drive digital transformation with Next-Generation Platform For Biotech And Pharma Industries. Through enhanced transparency, regulatory visibility and digital transformation of manual processes, the new solutions will allow life sciences companies to minimize regulatory risk, increase operational efficiencies and deliver products to customers faster while reducing rejections and waste of products.